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Abstract
Background: The World Health Organization (WHO) considers physical inactivity (PIA) as a critical noncommunicable
factor for disease and mortality, affecting more women than men. In 2013, the WHO set a 10% reduction of the PIA
prevalence, with the goal to be reached by 2025. Changes in the 2013–2017 period of physical inactivity prevalence in
the 28 European Union (EU) countries were evaluated to track the progress in achieving WHO 2025 target.
Methods: In 2013 and 2017 EU Special Eurobarometers, the physical activity levels reported by the International
Physical Activity Questionnaire of 53,607 adults were analyzed. Data were considered as a whole sample and country-
by-country. A χ2 test was used to analyze the physical inactivity prevalence (%) between countries, analyzing women
and men together and separately. Additionally, PIA prevalence was analyzed between years (2013–2017) for the overall
EU sample and within-country using a Z-Score for two population proportions.
Results: The PIA prevalence increased between 2013 and 2017 for the overall EU sample (p < 0.001), and for women
(p = 0.04) and men (p < 0.001) separately. Data showed a higher PIA prevalence in women versus men during both
years (p < 0.001). When separately considering changes in PIA by gender, only Belgium’s women and Luxembourg’s
men showed a reduction in PIA prevalence. Increases in PIA prevalence over time were observed in women from
Austria, Croatia, Germany, Lithuania, Malta, Portugal, Romania, and Slovakia and in men from Bulgaria, Croatia, Czechia,
Germany, Italy, Lithuania, Portugal, Romania, Slovakia, and Spain.
Conclusions: PIA prevalence showed an overall increase across the EU and for both women and men between 2013
and 2017, with higher rates of PIA reported for women versus men during both years. PIA prevalence was reduced in
only Belgium’s women and Luxembourg’s men. Our data indicate a limited gender-sensible approach while tacking
PIA prevalence with no progress reaching global voluntary reductions of PIA for 2025.
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Background
Physical inactivity (PIA) is a global risk factor for disease
and mortality, which is defined as individuals not meet-
ing the weekly Global Recommendations on physical
activity [1]. The physical activity recommendations aim
to provide guidance through primary prevention on the
dose-response relationship between physical activity and
health benefits and address the links between frequency,
duration, intensity, type and the total amount of physical
activity needed for the prevention of non-communicable
diseases [1]. In the World Health Organization (WHO)
European region, PIA is the attributable risk factor for
12.% of the type 2 diabetes, 8% of the colon cancers, and
9.7% of all-cause mortality anually. This burden repre-
sents a lifetime disease of 2.270 disability-adjusted life-
years [2]. Accordingly, conservative analyses have re-
ported direct and indirect annual health-care costs of
$11.743 and $3.829 million, respectively, for the Euro-
pean region [2].
The Global Action Plan (2013) positioned PIA as one
of the critical noncommunicable diseases factors, and set
for all countries a PIA reduction of 10% by 2025, relative
to each country’s baseline [3]. For this mandate, member
states were expected to develop national targets and in-
dicators based on the global monitoring framework [3].
Concurrently, member states had to link this framework
with a multisectoral policy represented in national plans
[3]. Since PIA prevalence is consistently higher in
women than in men [4–6], each country framework was
intended to consider gender-based approaches to de-
creasing PIA, in an effort to reduce the risks of morbid-
ity and mortality from non-communicable diseases [3].
Therefore, monitoring current levels and trends of PIA
prevalence with a gender-specific approach is crucial to
analyze any progress towards the goal of reduced PIA
prevalence [6]. Although there is limited availability of
objectively measured physical activity data (i.e., obtained
by accelerometry) at present, monitoring is possible
based on sex-disaggregated self-report data [7].
Regarding the European Union (EU), after considering
the WHO resolutions WHA51.17 (2000) and EB109/14
(2001), systematic surveys in its member states were car-
ried out since 2002 to monitor levels of PIA prevalence
with self-report data gathered from the short form of the
International Questionnaire of Physical Activity (IPAQ)
[8]. During the same years, scientific papers analyzing
the PIA prevalence of particular Eurobarometers were
published, such as the Special Eurobarometer 183.6
(2002) [9] and the Special Eurobarometer 412 (2012)
[10]. A further study observed PIA prevalence reductions
for those European countries that joined the EU before
2004 comparing the Special Eurobarometer 412 and the
Special Eurobarometer 246 between 2002 and 2005 [11].
Nevertheless, the picture is quite different in the 28-
country EU nowadays. In this regard, a recent pooled
analysis including available worldwide data through the
2013 Special Eurobarometer observed a gradual increase
of PIA prevalence in Central and Eastern Europe and
high-income Western countries [6].
Relevant to this matter, the publication of the Global
Action Plan (2013) coincided with the fieldwork of the
Special Eurobarometer 412, performed in late 2013. As
an outcome of the Global Action Plan, many countries
have now adopted national plans in different political
domains such as sustainable environment, public health,
sports promotion or active transport and in different set-
tings such as school- or work-related activity, all aimed
at reducing PIA prevalence [12]. Importantly here, most
of these containing gender-specific interventions [13].
Whilst the adoption of national plans to promote phys-
ical activity is encouraging, questions do exist as to the
quality and consistency of implementation [12]. With
this in mind, the 2018 publication of the new Special
Eurobarometer 472 regarding Sport and Physical Activity
seems relevant to analyze possible changes in PIA preva-
lence in the most recent period, 2013–2017. This ana-
lysis will help determine if any changes in PIA
prevalence have occurred towards the 2025 target of a
10% PIA reduction. Given the importance of gender-
specific interventions to tacking PIA in women and in
order to check progress and identify potential challenges,
a particular focus on the women’s PIA prevalence
changes is warranted [3].
This analysis aimed to track changes in PIA prevalence
between 2013 and 2017 in the 28 EU countries, analyzing
the respective Sport and Physical Activity Eurobarometer’s
data. For this, we analyzed the prevalence of PIA consider-
ing the between-country differences for both years and
the changes within-country between years. Our analysis
explored the sample as a whole and split by gender. Our
study assesses the progress in the fulfillment of the 10%
reduction of PIA prevalence for 2025. It also provides
comparison of the changes in PIA prevalence in individual
countries and the EU as a whole against the suitability of
policy action on PIA emerged from the Physical activity
strategy for the WHO European Region 2016–2025 [14]
and the Global action plans on physical activity for the pe-
riods 2013–2020 and 2018–2030 [3, 15].
Methods
Data source
In the EU, public opinion surveys are conducted recur-
rently and simultaneously on all state members by the
European Commission to inquire about physical activity
and sports participation among its citizens. These sur-
veys were conducted in 2002, 2005, 2009, 2013, and
2017 through the Sport and Physical Activity and Health
and Food Special Eurobarometers.
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For this analysis, data from two successive Eurobarom-
eter surveys were obtained, December 2013 (Special
Eurobarometer 412, published on March 2014, n = 27,
919) [16] and December 2017 (Special Eurobarometer
472, published on March 2018, n = 28,031) [17]. The
total sample (n = 55,950) was considered from the 28 EU
member countries (Austria, Belgium, Bulgaria, Croatia,
Cyprus, Czechia, Denmark, Estonia, Finland, France,
Germany [combined West and East Deutschland],
Greece, Hungary, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Netherlands, Poland, Portugal,
Romania, Slovakia, Slovenia, Spain, Sweden, and United
Kingdom), and Northern Ireland was not considered due
to its unique characteristics. Although Eurobarometers
respondents are aged 15 and over, only respondents over
the age of 18 were analyzed since the physical activity
recommendations are different for individuals under 18
years [1].
Eurobarometers use a multi-stage, random sampling
design. For this, the number of sampling points was
drawn with probability proportional to population size
and population density, covering the whole territory of
each country. For the sampling, a comparison between
the sample and each country population was carried out.
In this regard, gender, age, region, and the size of the lo-
cality were introduced in the iteration procedure. All in-
terviews are conducted face-to-face in people’s homes
and in the appropriate national language [16, 17]. Since
our analysis was performed considering data from a pub-
lic repository, our study was carried out addressing
STROBE guidelines when possible [18].
Measures
A modified version of the short form of the IPAQ was
used to determine the prevalence of PIA [8]. The IPAQ
measures the intensity, frequency, and duration of the
physical activity performed in the last seven days. This
information was obtained by the questions inquiring
about the number of days practicing vigorous and mod-
erate physical activity and walking activity and their re-
spective minutes during those days. In the 2013 and
2017 Special Eurobarometers, answers were truncated to
five different fixed possibilities instead of the classical
open solution to indicate the minutes performed in
every activity [8]. In this regard, a response of “30 mi-
nutes or less” was assumed to mean 15 min, a response
of “31 to 60 minutes” was assumed to mean 45min, a
response of “61 to 90 minutes” was assumed to mean 75
min, a response of “91 to 120 minutes” was assumed to
mean 105min, and a response of “more than 120 mi-
nutes” was assumed to mean 120min [10]. The instruc-
tions of the November 2005 version of the Guidelines
for data processing and analysis of the IPAQ short form
were used for analyzing the data [8]. This analysis was
implemented using a modified ad hoc spreadsheet avail-
able online [19]. Only individuals with at least one valid
intensity and duration of a particular intensity (i.e., both
variables with a different answer than “don’t know”)
were eligible for further analysis [11].
The Guidelines assume that vigorous intensity, moder-
ate intensity, and walking represent 8.0, 4.0, and 3.3
metabolic equivalents (MET), respectively [8]. Vigorous,
moderate, and walking MET-minutes/week are calcu-
lated from multiplying the selected MET values by the
minutes and by the days of each intensity. Thus, the
total physical activity MET-minutes/week is calculated
summing up the vigorous, moderate, and walking MET-
minutes/week scores.
In this regard, individuals are considered physically ac-
tive when performing (a) at least 3 days of vigorous in-
tensity activity of at least 20 min per day, (b) at least 5
days of moderate intensity activities and/or walking for
at least 30 min per day, or (c) at least 5 days combining
the aforementioned intensities achieving at least 600
MET-minutes/week. Individuals not reaching any of
those thresholds were considered to have a “low” phys-
ical activity level, thus being classified as physically
inactive.
Statistical analysis
The PIA prevalence between countries, entire sample
and separately for gender, were analyzed with a χ2 test
for both 2013 and 2017. Additionally, the PIA prevalence
was analyzed between both years (2013 and 2017) for
the overall EU sample and within-country (Austria,
Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark,
Estonia, Finland, France, Germany [combined West and
East Deutschland], Greece, Hungary, Ireland, Italy,
Latvia, Lithuania, Luxembourg, Malta, Netherlands,
Poland, Portugal, Romania, Slovakia, Slovenia, Spain,
Sweden, and United Kingdom), also as an entire sample
and separetly by gender, and using a Z-Score for two
population proportions. Data are represented as a per-
centage (%) with a 95% confidence interval (95% CI). A
priori alpha level was set at 0.05. Statistical analyses were
carried out using Microsoft Excel version 1709 (Micro-
soft Corporation; Redmond, Washington, United States
of America).
Results
Between the 28-country sample, significant differences
in the prevalence of PIA were observed in 2013 (n = 26,
507; χ2 = 1437,328; DF = 27; p < 0.001) and 2017 (n = 27,
100; χ2 = 1643,243; DF = 27; p < 0.001). In the same way,
significant differences between countries were also ob-
served in the prevalence of PIA for women in 2013 (n =
14,503; χ2 = 1006,693; DF = 27; p < 0.001) and 2017 (n =
14,873; χ2 = 1050,121; DF = 27; p < 0.001) and for men
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in 2013 (n = 12,004; χ2 = 481,643; DF = 27; p < 0.001)
and 2017 (n = 12,227; χ2 = 649,808; DF = 27; p < 0.001).
When comparing the prevalence of PIA between 2013
and 2017 (Table 1), PIA increased between years for the
overall EU sample. Not all the countries experienced in-
creases in PIA prevalence. In this sense, 17 countries
maintained their PIA prevalence (Belgium, Cyprus,
Denmark, Estonia, Finland, France, Greece, Hungary,
Ireland, Italy, Latvia, Luxembourg, Netherlands, Poland,
Slovenia, Sweden, and United Kingdom). Conversely, 11
countries reported increases in PIA prevalence between
years (Austria, Bulgaria, Croatia, Czechia, Germany,
Lithuania, Malta, Portugal, Romania, Slovakia, and
Spain). No reductions were observed for any countries
between such years.
When analyzing gender differences (Table 2), the
prevalence of PIA in the overall EU sample was higher
in women compared to men in both 2013 and 2017.
However, rates of in-country PIA prevalence between
genders varied by country for both years. For 2013 year,
women had higher PIA prevalence than men in Belgium,
Croatia, Cyprus, Czechia, France, Greece, Hungary,
Ireland, Italy, Malta, Poland, Portugal, Slovenia, Spain,
and the United Kingdom. For 2017, women had a higher
Table 1 Prevalence (expressed as a percentage) of adults not complying with the World Health Organization’s aerobic physical
activity recommendations in the European Union countries between 2013 and 2017
2013 2017 Z-score p-value
Prevalence (%) 95% CI Prevalence (%) 95% CI
European Union (n = 53,607) 38.1% 38.4–39.5% 41.7% 41.1–42.3% 8.43 < 0.001*
Country
Austria (n = 2014) 36.1% 33.1–39.0% 43.6% 40.5–46.6% 3.44 < 0.001*
Belgium (n = 2029) 46.4% 43.3–49.4% 44.5% 41.7–47.2% 0.86 0.39
Bulgaria (n = 1992) 41.1% 38.0–44.2% 49.3% 46.2–52.4% 3.68 < 0.001*
Croatia (n = 2007) 32.3% 29.4–35.2% 45.9% 42.9–49.0% 6.24 < 0.001*
Cyprus (n = 969) 64.6% 60.3–68.9% 62.1% 57.8–66.5% 0.79 0.43
Czechia (n = 2004) 37.3% 34.3–40.3% 42.7% 39.7–45.8% 2.48 0.01*
Denmark (n = 1986) 30.5% 27.6–33.4% 31.4% 28.5–34.3% 0.44 0.66
Estonia (n = 1967) 31.4% 28.5–34.3% 29.7% 26.8–32.6% −0.83 0.41
Finland (n = 1955) 29.1% 26.2–32.0% 29.9% 27.1–32.7% 0.39 0.69
France (n = 1992) 42.6% 39.5–45.6% 45.0% 41.9–48.1% 1.10 0.27
Germany (n = 2792) 19.4% 17.2–21.6% 25.9% 23.7–28.1% 4.05 < 0.001*
Greece (n = 1952) 48.1% 45.0–51.2% 50.6% 47.4–53.7% 1.09 0.28
Hungary (n = 2026) 42.6% 39.6–45.7% 42.2% 39.2–45.2% −0.21 0.84
Ireland (n = 1959) 37.9% 34.9–41.0% 42.2% 39.1–45.3% 1.95 0.051
Italy (n = 2011) 58.5% 55.4–61.6% 62.4% 59.4–65.4% 1.79 0.07
Latvia (n = 1948) 25.7% 22.9–28.4% 28.6% 25.7–31.4% 1.44 0.15
Lithuania (n = 1967) 33.9% 31.0–36.9% 44.5% 41.4–47.5% 4.77 < 0.001*
Luxembourg (n = 970) 33.9% 29.7–38.1% 29.1% 25.0–33.2% −1.62 0.10
Malta (n = 988) 62.0% 57.7–66.3% 70.9% 66.9–74.9% 2.94 < 0.001*
Netherlands (n = 2004) 23.9% 21.2–26.5% 24.3% 21.6–26.9% 0.21 0.83
Poland (n = 1905) 55.3% 52.2–58.5% 53.2% 50.1–56.4% −0.92 0.35
Portugal (n = 2086) 59.3% 56.2–62.3% 68.2% 65.4–71.1% 4.27 < 0.001*
Romania (n = 1941) 34.3% 31.3–37.3% 50.4% 47.2–53.5% 7.15 < 0.001*
Slovakia (n = 2038) 37.6% 34.5–40.6% 45.6% 42.6–48.6% 3.68 < 0.001*
Slovenia (n = 2112) 39.4% 36.5–42.3% 37.2% 34.2–40.2% −1.04 0.30
Spain (n = 1989) 28.4% 25.6–31.3% 34.0% 31.0–36.9% 2.66 0.01*
Sweden (n = 2024) 22.0% 19.4–24.6% 23.0% 20.5–25.6% 0.56 0.57
United Kingdom (n = 1980) 40.6% 37.5–43.7% 37.1% 34.1–40.0% −1.60 0.11
CI Confidence intervals
*Significant increases in physical inactivity prevalence (p ≤ 0.05)
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prevalence of PIA for Austria, Cyprus, France, Greece,
Ireland, Malta, Portugal, Spain, and United Kingdom in
comparison with men.
When analyzing the subsamples of women and men
separately, increases in PIA prevalence also varied by
country and by year. Particularly, increases in PIA preva-
lence for women between 2013 and 2017 were observed
for Austria, Croatia, Germany, Lithuania, Malta, Portugal,
Romania, and Slovakia. Reductions in PIA prevalence for
woman were only noted in Belgium. For men, increases in
the PIA prevalence between 2013 and 2017 were observed
for Bulgaria, Croatia, Czechia, Germany, Italy, Lithuania,
Portugal, Romania, Slovakia, and Spain. Reductions in
men PIA prevalence were only observed in Luxembourg.
Discussion
The main findings of this study were: (a) the PIA preva-
lence increased between 2013 and 2017 for the overall EU
sample and both women and men separately; (b) a higher
prevalence of PIA was observed in women for both 2013
and 2017 in comparison with men; (c) reductions in PIA
prevalence were only observed in Belgian women and
Luxembourg men; and (d) increases in PIA prevalence
were observed for women in Austria, Croatia, Germany,
Lithuania, Malta, Portugal, Romania, and Slovakia, and for
men in Bulgaria, Croatia, Czechia, Germany, Italy,
Lithuania, Portugal, Romania, Slovakia, and Spain. In sum-
mary, reductions were rare and increases were common
regarding PIA prevalence for both women and men.
To the best of our knowledge, this is the first study
reporting data from the Special Eurobarometer 472, the
most current dataset regarding physical activity data for
EU countries (2018). Although a previous study reported
data regarding the Special Eurobarometer 412 [10], there
are two important differences to consider when compar-
ing findings here with those reported previously. Firstly,
Gerovasili et al. study [10] characterized the physically
inactive individuals based on the total minutes per-
formed in vigorous and moderate activity, with walking
considered a moderate activity. Our study used the
IPAQ Guidelines for data processing and analysis, and
considered a “low” physical activity as being physically
inactive, and also discerned between moderate activity
and walking [8]. Gerovasili and colleagues also only ana-
lyzed physical activity among adults between 18 to 64
years old, yet our analysis consisted of adults from 18
and older (i.e., without an upper limit) since the WHO
recommendations are virtually the same for aerobic
physical activity regardless of upper age [1]. These two
factors could account for the lower prevalence of PIA in
Gerovasili et al. and should be taking into consideration
when comparing the data [10].
Only one previous study compared changes between
years in the prevalence of PIA using the Special
Eurobarometer data between 2002 and 2005 [11]. In this
study, Mayo and colleagues showed a reduction of PIA
prevalence between years with dissimilar changes be-
tween countries [11]. In this regard, there may be rela-
tively higher PIA prevalence in our study due to several
reasons. Firstly, it is essential to note that in Mayo’s
study only the fifteen countries that entered the EU
before May 2014 were analyzed (i.e., Austria, Belgium,
Denmark, Finland, France, Germany Greece, Ireland,
Italy, and Luxemburg) [11], and some of these being
countries with historically lower PIA prevalence [10].
Our study included all 28 EU countries, with some
countries having a relatively higher prevalence of PIA,
such as Cyprus or Malta [10]. Secondly, the responses in
the Mayo study were the classical open solution to indi-
cate minutes performed in every activity [11], as is indi-
cated in the IPAQ Guidelines [8]. However, the last two
Special Eurobarometers (i.e., 2013 and 2017) truncated
the possible answers to five different fixed possibilities
[8]. This truncation will tend to increase the replicability
of the data due to a narrowed range of possibilities to
answer [20, 21]. Additionally, it will reduce the minutes
reported as a consequence of creating an artificial aver-
age. This false average will tend to result in higher levels
of PIA in comparison with previous years [10, 11]. In
this regard, a standardized instrument throughout the
years to remove the limiting comparability of these
survey data when using the IPAQ is needed, as was pre-
viously pointed out [6]. There have been previous at-
tempts to standardize instruments, questions, and ways
to report results in European surveys, but with a limited
implementation success in the delivery [22].
As was previously explained, our data cannot be
directly compared with that of previous reports, but
changes observed between both reports (2002 vs. 2005
and 2013 vs. 2017) are potentially comparable since each
shared the same response characteristics [11]. In this
sense, there was a general reduction in the PIA preva-
lence in Mayo et al. for the whole sample and women
and men separately [11], while in this analysis the PIA
prevalence of the whole sample and for women and men
increased. In particular, for the sample of every country
of the fifteen analyzed in the previous report [11], none
reduced the PIA prevalence in the 2013–2017 period. In
this 15-country sample, four possible cases happened:
Firstly, Austria, Germany, and Sweden reduced the PIA
prevalence in the period 2002–2005 but increased such
prevalence in the period 2013–2017. Secondly, Portugal
and Spain did not change the PIA prevalence in the
2002–2005 but increased such prevalence in the 2013–
2017 period. Thirdly, Belgium, France, Greece,
Netherlands, and the United Kingdom did reduce the
PIA prevalence in the period 2002–2005, but without
showing changes in the 2013–2017 one. Lastly,
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Denmark, Finland, Ireland, Italy, and Luxembourg did
not change the PIA prevalence in any of both periods.
Globally, our data agree with a pooled analysis of 358
population-based surveys performed through 2016, in
which the PIA prevalence in Central and Eastern Europe
and high-income Western countries gradually increased
[6]. In this study, data were analyzed until 2013 Special
Eurobarometer, including some country-specific surveys
until 2016 (e.g., Germany). Since our data show in-
creases until 2017, this suggests no progress in reducing
the PIA prevalence to reach the 2025 global 10% reduc-
tion target [3]. As previously indicated by the Bangkok
Declaration, our data recognize that previous effort to
decrease PIA prevalence to reach such global reduction
target has been insufficient [23]. This consideration
points out the urgent need to strengthen policy action
[23], following the objectives proposed by the new
Global Action Plan and starting to work in a new frame-
work with 20 policy actions within four strategic objec-
tives [15].
When considering gender, reductions in PIA preva-
lence in the 2013–2017 period were only observed in the
subsample of Belgium’s women and Luxembourg’s men.
While to find direct causations when reducing PIA is
challenging to bring in, particular interventions and ac-
tions influencing this behavior are possible to be de-
scribed. For women [6], reductions of PIA prevalence in
Belgium’s women were also observed in the 2002–2005
period [11]. As an example, a scientifically analyzed
wide-scale intervention in Flanders (i.e., ‘10,000 Steps
Flanders’) showed high levels of awareness, adoption,
and implementation [24], while effectively reducing PIA
prevalence with enduring effects throughout years [25].
On the other hand, physical activity-related health pro-
motion campaigns, which are required to be freely
broadcasted by law, have been performed in Wallonia
region in both public and private television and radio
channels [26]. This all suggests a defined policy to tackle
PIA, while showing a genuine interest in tacking PIA at
a policy level within those years [27]. Nevertheless, some
issues in leadership and coordination at the national and
sub-national level (i.e., the administrative structure of
the country), and lack of cross-sectional coordination re-
garding “health-enhancing physical activity” were re-
ported, highlighting scope for improvement when
tackling PIA [28]. For men [6], Luxembourg showed re-
ductions in the 2013–2017 period, but no changes in the
period between 2002 and 2005. During those years,
Luxembourg showed an improvement regarding local
authority and local area perceptions offering opportun-
ities to be physically active, pointing out a trend for re-
ducing PIA prevalence [29]. Additionally, scientific
efforts were made to understand the compliance of Lux-
embourgishs with physical activity recommendations
and the potential demographic, socioeconomic, and per-
ceptive factors influencing this behaviour at policy level,
in order to inform decision-makers to target risk popula-
tions and develop preventive programs tacking physical
inactivity [30].
Other changes were observed between periods when
analyzing women and men separately in comparison
with the study of Mayo et al. [11]: Firstly, Austria and
Germany reduced the PIA prevalence in the period
2002–2005 but increased such prevalence in the period
2013–2017, that same pattern also occurring in Italian
men. Secondly, Portugal’s PIA prevalence did not change
between 2002 and 2005, yet increased between 2013 and
2017. This same pattern of change was also noted in
Spanish men. Thirdly, France, Greece, Netherlands, and
Sweden showed reductions in PIA prevalence for the
period 2002–2005, yet no changes between 2013 and
2017 were observed. This same pattern was evident for
Luxembourgs’ women and Belgium’s men. Lastly,
Denmark, Finland, Ireland, and the United Kingdom did
not report changes in PIA prevalence during either time
frame, and this was also the pattern for women in Italy
and Spain.
When comparing period changes in PIA prevalence
between women and men, Belgium was the only country
that showed gender differences in 2013 and then no gen-
der differences in 2017. Some countries, such as
Hungary, Latvia, Poland, and Slovenia eliminate gender
differences between years without changes in the preva-
lence of women and men between years (i.e., no statis-
tical differences were observed for those prevalence
changes in women and men). On the other hand, coun-
tries such as Denmark, Estonia, Finland, Netherlands,
and Sweden maintained no differences in gender PIA
prevalence while reporting no changes between years.
Some countries showed an increase in prevalence in
both sexes while maintaining no differences in the preva-
lence of women and men, such as Germany, Lithuania,
Romania, or Slovakia. Bulgaria maintained no gender dif-
ferences with increases men PIA prevalence. Other coun-
tries as Cyprus, France, Greece, Ireland, and the United
Kingdom had gender differences at both time points with
no increases in PIA prevalence between years. Malta and
Spain maintained a gender differences with increases in
women and men PIA prevalence, respectively. Lastly,
Austria and Luxembourg changed from no gender differ-
ences of PIA prevalence in 2013 to reporting differences
in 2017. In Austria, there was an increase in PIA for
women, and in Luxembourg there was a decreasae in PIA
prevalence for men. Croatia eliminated gender differences
by increasing the PIA prevalence more in men than in
women, while Czechia and Italy saw gender differences
disappear through an increased PIA prevalence in women.
Portugal maintained PIA prevalence gender differences
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while both genders reported PIA increases over time.
These data show a limited gender-sensible approach while
tackling PIA prevalence, particularly in the cases of
Austria, Croatia, Czechia, Italy, Malta [6].
The previous study analyzing gender differences in
PIA across 15 EU countries between 2002 and 2005 ob-
served differences in both years with higher levels for
women [11], which is consistent with our data. Neverthe-
less, we observed these gender differences after an in-
crease of PIA, not a reduction. Interestingly, women in
Belgium showed a decrease in PIA prevalence in both
studies, which suggests a steady policy action for tackling
PIA in women. This reduction occurred, nonetheless,
despite not having suitable policy indicators of women
physical activity participation in its national plan for the
previous period [11, 31] or this particular one [26, 32].
Thus, this higher prevalence of PIA in women in com-
parison with men observed in our analysis is recurrent
in the literature and consistent across countries [4–6]
and timeline [4, 6], as data consistently show women
participate in less leisure-time physical activity than
men. To eliminate this systematic difference, more safe,
accessible, and tailored activities are needed while chan-
ging cultural norms, traditional roles, and lack of social
and community support. Only more rounded and sens-
ible policies in which barriers are truly understood with
structured policy delivery systems in place will help to
eliminate or at least reduce the gender gap [4, 6].
The findings here should be considered in the light of
some limitations. The differences in definitions, question-
naires, answers possibilities, methodological particularities,
and means of analyzing data potentially limit reliable com-
parisons and the generalization of the findings [10]. In
contrast, it is known that the IPAQ questionnaire tends to
overestimate the physical activity reported [33]. That said,
our data are broadly consistent with the literature and
allow for tracking changes in PIA prevalence in any case.
Future Eurobarometers should amend these differences in
methodology, standardizing survey instruments to in-
crease the comparability of the Eurobarometers, building
up as a consequence better databases.
Conclusions
The PIA prevalence increased in the overall EU sample
between 2013 and 2017 and for both women and men
separately. A higher prevalence of PIA was observed in
women for both 2013 and 2017. Large differences were
observed by country and year. Reductions in PIA preva-
lence were only for Belgium’s women and Luxembourg’s
men. Increases in PIA prevalence were reported for
women in Austria, Croatia, Germany, Lithuania, Malta,
Portugal, Romania, and Slovakia, and for men in
Bulgaria, Croatia, Czechia, Germany, Italy, Lithuania,
Portugal, Romania, Slovakia, and Spain.
Between years, some countries eliminated gender dif-
ferences without showing changes in PIA prevalence,
such as Hungary, Latvia, Poland, and Slovenia. Other
maintained similar gender rates of PIA prevalence while
showing no changes over time, such as Denmark,
Estonia, Finland, Netherlands, and Sweden. Overall, the
changes noted in this study highlight limited success of
gender-specific approaches to addressing PIA preva-
lence, while also suggesting no progress in reaching the
2025 target of a 10% reduction in PIA prevalence. The
findings arising from this study should be used to help
to strengthen the following policy action in the EU
countries. Priorities in policy development should
include defining the policy actions that are needed to
progress in the accomplishment with the new PIA
prevalence reduction goals for 2030 while, at the same
time, reducing the gender disparities in PIA prevalence.
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